Super Session 4 - Unmet medical needs in women – treatments around the corner
Wednesday, September 14, 2016
•
S5
•
3:15 PM
>
4:15 PM
•
Super Session 4 - Unmet medical needs in women – treatments around the corner
•
Plenary Room A3
Co-Hosted by Bayer and Innomedica
Medical conditions only affecting women, including endometriosis, pregnancy complications and premenstrual dysphoric disorder, represent high unmet medical needs. In the absence of treatments targeting the causes of the condition, available alternatives have so far been limited to alleviating symptoms. However, there are currently several companies in the Nordics with potential treatments for these conditions being tested, some in advanced clinical stages. The session will focus on providing an overview of the area, showcasing a few companies from the Nordics with ongoing developments and discussing the challenges and potential in coming years.
Moderator: Ms. Tanja Dowe, Managing Partner, Innomedica
Speakers:
Mr. Olivier Martin Fischer, Gynecological Therapies, Pharmaceuticals Division, Bayer
Mr. Tomas Eriksson, CEO, A1M Pharma
Dr. Lena Degling Wikingsson, CEO, Dilafor
Ms. Gunilla Lundmark, CEO, Pharmanest
Mr. Peter Nordkild, CEO, Asarina
Dr. Risto Lammintausta, CEO, Forendo
|